FIRST TIME VISITOR? CLICK HERE!

Welcome to AIDS-Drugs-Online.com.

Our website ensures an easy ordering process for affordable HIV/AIDS and PrEP medications, as well as protection of our customers' information. Having an account on our website allows you to place your orders easily, upload your prescriptions safely, view your order history, and even earn discounts.

If you have not ordered from us before:
You can create an account for free by clicking here.

Please take a moment to learn how to order. If you have any trouble, please call us at 1-888-243-7675.

We invite you to explore our website and save money on your HIV/AIDS and PrEP medications!

Myhep Lvir 400mg/90mg 28 Tablets
28 tablet(s)

Myhep Lvir 400mg/90mg 28 Tablets

$493.24 USD
+ shipping and handling
0 Review(s)

Prescription required

Active Ingredient(s): ledipasvir, sofosbuvir
Manufacturer: Mylan
Country of origin: India
Known Names: Harvoni
28 tablet(s)
Active Ingredient(s): ledipasvir, sofosbuvir
Manufacturer: Mylan
Country of origin: India
Knows Names: Harvoni

What is MyHep LVIR?

MyHep LVIR™ is an antiviral medication formulated by Mylan Pharmaceuticals, a global company that specializes in the manufacture of generic medical products. Each tablet is composed of 90mg of ledipasvir, a viral nonstructural protein 5A (NS5A) inhibitor, and 400mg of sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase. This drug is prescribed for the treatment of chronic hepatitis C, as it reduces the viral load and transmission within the body. Each bottle of MyHep LVIR™ contains 28 tablets that must be stored at a temperature between 15℃ and 30℃.

Dosing

1 tablet of MyHep LVIR™ should be taken once daily after eating. The duration of treatment ranges from 8 to 24 weeks; the appropriate duration depends on the genotypes of hepatitis C virus. It is recommended to take the medication at the same time every day, preferably in the morning to prevent possible sleeping disorders. For the best treatment outcomes, patients should avoid missing any doses.

Contraindications

MyHep LVIR™ is contraindicated in patients who are allergic to ledipasvir and sofosbuvir, as well as the other excipients in the drug. Additionally, this medication is also contraindicated in patients taking rosuvastatin.

Side Effects

Commonly reported side effects associated with MyHep LVIR™ are:

  • Nausea;
  • Anemia;
  • Fatigue;
  • Insomnia.

Consult your health-care provider if you experience any of the following:

  • Decreased appetite;
  • Shivering;
  • Difficult breathing;
  • Cramps.

Carefully read to the product instruction manual for a detailed list of possible side effects.

Precautions

You should not use MyHep LVIR™ with other formulations that contain sofosbuvir. To prevent the exacerbation of other medical conditions, caution must be exerted in certain cases.

  • Use with caution if you have decompensated cirrhosis or are awaiting liver transplant or are post-liver transplant, as the efficacy of using this drug under these circumstances has not yet been examined;
  • Use with caution if you have severe bradycardia and heart block. Some patients have experienced a severely slow heart rate and heart blocks when the drug formulation is used in combination with amiodarone, or other drugs that lower the heart rate.

Patients with serious medical conditions must be carefully monitored to avoid complications.

Drug Interactions

MyHep LVIR™ contains 2 different active ingredients that individually interact with certain drugs, including rifampicin, phenytoin, and carbamazepine. Interactions with alcohol is unknown. Carefully refer to the product instruction manual for a detailed list of possible drug interactions. Inform your doctor of all medications and supplements you are taking in order to reduce the risks of harmful drug interactions.

Pregnancy & Lactation

This medication is not recommended for use in pregnant or breastfeeding patients. Your doctor will discuss the risks and benefits of using this drug in necessary cases.

Overdosage

Currently, the highest documented doses of ledipasvir and sofosbuvir were 120mg taken twice daily for 10 days and a single dose of 1200mg, respectively. The healthy research subjects did not experience any unpleasant effects; however, the consequences of higher doses remain unknown. Patients who have accidentally overdosed on MyHep LVIR™ must be monitored carefully for any evidence of toxicity. Standard supportive measures, such as monitoring the vital signs and clinical symptoms, are necessary for adequate recovery. If you suspect an overdose, call your local poison control center.

Alternative Brand Names

An alternative brand name is Harvoni®, which contains equal doses ledipasvir and sofosbuvir.

There are no reviews yet
Be the first to review “Myhep Lvir 400mg/90mg 28 Tablets”
Star

Reviews are only written by verified customers who have purchased this product.

Related Products

Reset your password

Please enter your email below, and we will send you a new password.

Still having trouble signing in?

If you're unable to reset your password, please call Customer Service at 1-888-243-7675.